SENVELGO

Описание товара

About SENVELGO

SENVELGO is a prescription medication containing the active ingredient VELAGLIFLOZIN (VELAGLIFLOZIN L-PROLINE MONOHYDRATE), used to treat type 2 diabetes mellitus. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Key Benefits & Uses

• SENVELGO helps to lower blood sugar levels by reducing the amount of glucose reabsorbed by the kidneys and promoting its excretion in the urine.
• It also helps to reduce blood pressure and fluid buildup in the body, which can reduce the risk of cardiovascular events.
• SENVELGO is used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.

Active Ingredient & Action

VELAGLIFLOZIN (VELAGLIFLOZIN L-PROLINE MONOHYDRATE) works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the filtrate back into the bloodstream. By blocking this protein, VELAGLIFLOZIN reduces the amount of glucose reabsorbed and increases its excretion in the urine, thereby lowering blood sugar levels.

Important Notes

SENVELGO may increase the risk of dehydration, especially in patients with a history of kidney disease or those taking other medications that increase urine production. Patients should drink plenty of water and monitor their urine output while taking SENVELGO. Additionally, patients with a history of bladder cancer or those with a history of pancreatitis should use SENVELGO with caution. Consult your doctor or pharmacist for more information.